吸烟与多发性硬化的关联:综述
本综述探讨吸烟作为多发性硬化(MS)环境风险因素及其对疾病活动与预后的影响。吸烟通过促炎和神经毒性机制增加MS风险并加重病情,部分吸烟相关不良结局可逆,强调戒烟咨询的重要性。
要点
- 吸烟是多发性硬化的环境风险因素,并与疾病活动及预后不良相关。
- 吸烟通过肺部促炎级联和抗原交叉反应增加自身免疫风险,烟雾成分可直接神经毒性。
- 吸烟的MS患者疾病活动更高、脑萎缩更快、残疾负担更重,部分结局可逆。
核心结论
- 吸烟与多发性硬化的风险、疾病活动和不良预后相关,应努力降低MS患者吸烟率。
研究设计与样本
- 综述,总结吸烟与多发性硬化关联的观察性证据与机制。
主要发现
- 吸烟的MS患者疾病活动率更高、脑萎缩速度更快、残疾负担更大。
- 吸烟通过肺部促炎级联及抗原交叉反应增加MS风险,烟雾成分可直接神经毒性。
- 部分吸烟相关结局可逆,使戒烟咨询成为关键。
临床怎么用
- 对MS患者应进行戒烟咨询,以改善疾病活动和预后。
- 需进一步分析吸烟加重MS预后的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cigarette smoking is a common environmental exposure and addiction, which has severe health consequences. Smoking is a risk factor for multiple sclerosis (MS); also, smoking has been associated with disease activity and overall prognosis for patients with MS. OBSERVATIONS: Cigarette smoking is an irritative agent on the lungs, in which a proinflammatory cascade starts that culminates in autoimmunity. Inflammation may increase the risk of MS in some individuals, in a process driven by antigen cross-reactivity between lung antigens and myelin antigens. Genetics plays a central role in the individual predisposition to mounting an autoimmune reaction. Also, free radicals, cyanates, and carbon monoxide in cigarette smoke may be directly toxic to neurons. Patients with MS who smoke have higher rates of disease activity, faster rates of brain atrophy, and a greater disability burden. Some of the outcomes of smoking were found to be reversible, which makes counseling key. CONCLUSIONS AND RELEVANCE: The pathways involved in cigarette smoking should be further analyzed to understand the mechanisms whereby smoking worsens MS prognosis. The proinflammatory and neurotoxic outcomes of cigarette smoking may be shared by other environmental exposures, such as pollution and organic solvents. From a global perspective, efforts should be made to diminish the prevalence of cigarette smoking in patients with MS.
引用
- Rosso M, Chitnis T. Association Between Cigarette Smoking and Multiple Sclerosis: A Review. JAMA Neurol. 2020. PMID: 31841592. doi:10.1001/jamaneurol.2019.4271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。